Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics interviews Kirsten Axelsen, Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute where they discuss drug prices, their opportunity costs, and the effect today’s prices have on future drug developments.

Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics interviews Kirsten Axelsen, Senior Policy Advisor at DLA Piper &amp; Non-Resident Fellow at the American Enterprise Institute where they discuss drug prices, their opportunity costs, and the effect today’s prices have on future drug developments.

Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute, Kirsten Axelsen

Welcome to Perspectives, a signature podcast series from the Leerink Center for Pharmacoeconomics. Hosted by Dr. Mel Whittington, a health economist and Head of the Center for Pharmacoeconomics, we will be hearing from individuals across the industry to better understand and appreciate the societal impact of healthcare innovations.

Share Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute, Kirsten Axelsen

Sign up to save your podcasts

Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute, Kirsten Axelsen

Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute, Kirsten Axelsen